493 results on '"Graupera, Isabel"'
Search Results
2. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD
3. Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis
4. Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis
5. Screening for Fibrosis Promotes Lifestyle Changes: A Prospective Cohort Study in 4796 Individuals
6. Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular Profiling
7. Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
8. Position paper of the Catalan Society of Gastroenterology about hepatic elastography 2022
9. Documento de posicionamiento de la «Societat Catalana de Digestologia» sobre elastografía hepática 2022
10. Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease
11. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
12. A global research priority agenda to advance public health responses to fatty liver disease
13. Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease
14. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
15. Consenso AEEH «Consenso sobre métodos de detección y derivación de enfermedades hepáticas prevalentes ocultas»
16. Impact of the COVID-19 pandemic on the care and outcomes of people with NAFLD-related cirrhosis
17. Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population
18. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
19. Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease
20. Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure
21. Screening for fibrosis to diagnose liver diseases early: the LIVERSCREEN project
22. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
23. LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
24. WED-155 A ratio of exchangeable copper below 15% accurately excludes Wilson disease and may be useful for the first-line ethiologic work-up within a liver unit
25. WED-181 Use of metallothionein 1 as an ancillary tool for the diagnosis of Wilson disease
26. OS-059 Unveiling Socioeconomic Disparities on Liver Disease: A Comparative Study of ALD, MASLD, and MetALD Patients
27. TOP-241-YI Longitudinal changes in liver stiffness measurements in a population-based screening cohort of 5, 517 participants
28. FRI-211 The presence of autoimmune characteristics in metabolic associated steatosis liver disease patients increases the risk of liver disease progression. Study from the multicentric spanish register (HEPAMET)
29. WED-284-YI The Fatty Liver Index (FLI) is more accurate than FIB-4 for detection of advanced liver fibrosis in patients with type-2 Diabetes Mellitus (T2DM) in Primary Care
30. FRI-219-YI Recompensation and liver function improvement in patients with decompensated cirrhosis due to metabolic-dysfunction associated steatotic liver disease (MASLD): a retrospective cohort study
31. THU-056 Soluble PD-L1 levels as predictors of ACLF in decompensated cirrhosis: findings from two independent cohorts
32. OS-005-YI Single-cell RNA sequencing analysis in alcohol-related liver disease identifies specific cell subpopulations characterized by an inflammatory profile in alcohol-associated hepatitis
33. WED-055 Effect of long-term treatment with Simvastatin and Rifaximin in mitochondrial and proinflammatory pathways in patients with decompensated cirrhosis. A single-cell RNA seq analysis in PBMCs
34. Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF)
35. Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure
36. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis
37. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
38. Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with β-blockers and ligation
39. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target
40. Trajectory analysis of hepatic stellate cell differentiation reveals metabolic regulation of cell commitment and fibrosis
41. LiverPRO for the Prediction of Significant Liver Fibrosis in Primary Care: Development, Validation, and Prognostic Evaluation of a Novel Score
42. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia
43. Screening for fibrosis promotes life-style changes. A prospective cohort study in 4,796 individuals
44. Clinical epidemiology of non-alcoholic fatty liver disease in children and adolescents. The LiverKids: Study protocol
45. Position paper of the Catalan Society of Gastroenterology about hepatic elastography 2022
46. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial
47. High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study
48. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
49. Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-analysis
50. Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.